Literature DB >> 17603215

Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes.

Xin Li1, Stacie Bratton, Anna Radominska-Pandya.   

Abstract

It is widely believed that the UGT1A isoforms, UGT1A8 and -1A10, are expressed exclusively in extrahepatic tissues. In this work, human primary hepatocytes from six donors were analyzed for UGT1A8 and -1A10 mRNA expression by semi-quantitative RT-PCR. New primers to amplify UGT1A8 mRNA were designed and found to differ from those previously published. We demonstrated that UGT1A8 and -1A10 mRNA are expressed in hepatocytes. Although basal UGT mRNA levels were detected in untreated hepatocytes, significant up-regulation of the levels of mRNA for these isoforms were seen after treatment with 3-methylcholanthrene (3-MC) and rifampicin (Rif). RT-PCR products for all UGTs were sequenced and unambiguously identified as matching the corresponding cDNA. The discovery of these isoforms in hepatocytes is a novel discovery and will stimulate studies on the potential role for these isoforms in hepatic detoxification.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17603215      PMCID: PMC2275121          DOI: 10.2133/dmpk.22.152

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  32 in total

1.  In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance.

Authors:  M G Soars; B Burchell; R J Riley
Journal:  J Pharmacol Exp Ther       Date:  2002-04       Impact factor: 4.030

2.  Cloning and characterization of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 gene promoters: differential regulation through an interior-like region.

Authors:  Philip A Gregory; Dione A Gardner-Stephen; Rikke H Lewinsky; Kym N Duncliffe; Peter I Mackenzie
Journal:  J Biol Chem       Date:  2003-07-07       Impact factor: 5.157

3.  Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in Caco-2 cells--potential role in carcinogen bioinactivation.

Authors:  A Galijatovic; Y Otake; U K Walle; T Walle
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

4.  Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3.

Authors:  Yue-Hua Huang; Alema Galijatovic; Nghia Nguyen; Donald Geske; Deirdre Beaton; Judith Green; Mark Green; Wilbert H Peters; Robert H Tukey
Journal:  Pharmacogenetics       Date:  2002-06

5.  Human UDP-glucuronosyltransferase 1A5: identification, expression, and activity.

Authors:  Moshe Finel; Xin Li; Dione Gardner-Stephen; Stacie Bratton; Peter I Mackenzie; Anna Radominska-Pandya
Journal:  J Pharmacol Exp Ther       Date:  2005-08-24       Impact factor: 4.030

6.  A 66-base-pair enhancer module activates the expression of a distinct isoform of UDP-glucuronosyltransferase family 1 (UGT1A2) in primary hepatocytes.

Authors:  Y Emi; A Ohnishi; T Kajimoto; S i Ikushiro; T Iyanagi
Journal:  Arch Biochem Biophys       Date:  2000-06-15       Impact factor: 4.013

Review 7.  Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract.

Authors:  R H Tukey; C P Strassburg
Journal:  Mol Pharmacol       Date:  2001-03       Impact factor: 4.436

8.  Differential and special properties of the major human UGT1-encoded gastrointestinal UDP-glucuronosyltransferases enhance potential to control chemical uptake.

Authors:  Nikhil K Basu; Marco Ciotti; Myung S Hwang; Labanyamoy Kole; Partha S Mitra; Jeong W Cho; Ida S Owens
Journal:  J Biol Chem       Date:  2003-10-13       Impact factor: 5.157

Review 9.  Regulation of UDP glucuronosyltransferase genes.

Authors:  P I Mackenzie; P A Gregory; D A Gardner-Stephen; R H Lewinsky; B R Jorgensen; T Nishiyama; Wen Xie; A Radominska-Pandya
Journal:  Curr Drug Metab       Date:  2003-06       Impact factor: 3.731

10.  FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity.

Authors:  Olivier Barbier; Ines Pineda Torra; Audrey Sirvent; Thierry Claudel; Christophe Blanquart; Daniel Duran-Sandoval; Folkert Kuipers; Vladimir Kosykh; Jean-Charles Fruchart; Bart Staels
Journal:  Gastroenterology       Date:  2003-06       Impact factor: 22.682

View more
  4 in total

1.  Quantification of human uridine-diphosphate glucuronosyl transferase 1A isoforms in liver, intestine, and kidney using nanobore liquid chromatography-tandem mass spectrometry.

Authors:  David E Harbourt; John K Fallon; Shinya Ito; Takashi Baba; Joseph K Ritter; Gary L Glish; Philip C Smith
Journal:  Anal Chem       Date:  2011-12-05       Impact factor: 6.986

Review 2.  Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients.

Authors:  G Zaza; S Granata; F Sallustio; G Grandaliano; F P Schena
Journal:  Clin Exp Immunol       Date:  2009-11-24       Impact factor: 4.330

3.  Tissue-specific and ubiquitous expression patterns from alternative promoters of human genes.

Authors:  Edwin Jacox; Valer Gotea; Ivan Ovcharenko; Laura Elnitski
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

4.  Dopamine is a low-affinity and high-specificity substrate for the human UDP-glucuronosyltransferase 1A10.

Authors:  Katriina Itäaho; Michael H Court; Päivi Uutela; Risto Kostiainen; Anna Radominska-Pandya; Moshe Finel
Journal:  Drug Metab Dispos       Date:  2008-12-30       Impact factor: 3.922

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.